AI Science Tracker
EN

Machine learning-based risk prediction model for arteriovenous fistula stenosis

The Central Hospital of Wuhan · 29 Mar 2025 · medicine

Discovery

Machine learning-based risk prediction model for arteriovenous fistula stenosis

Source check: Source checked. Not independent scientific confirmation.

Finding: Seven models used retrospective clinical data from 974 hemodialysis patients to predict AV-fistula stenosis; XGBoost AUC 0.829, with prospective validation still needed before clinical use. This record is limited to the study result and does not establish independent replication or real-world benefit.

Technology: XGBoost

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Seven models used retrospective clinical data from 974 hemodialysis patients to predict AV-fistula stenosis; XGBoost AUC 0.829, with prospective validation still needed before clinical use.
Test and result
Seven models used retrospective clinical data from 974 hemodialysis patients to predict AV-fistula stenosis; XGBoost AUC 0.829, with prospective validation still needed before clinical use.
Limitation / still unknown
No prospective clinical benefit or broader external validity is established by the documented study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11954292/ · https://doi.org/10.1186/s40001-025-02490-x · https://europepmc.org/article/MED/40156016

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.